DOCSLIB.ORG

Ulla Feldt-Rasmussen

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Ulla Feldt-Rasmussen ULLA FELDT-RASMUSSEN Professor, Chief Physician, Department of Medical Endocrinology MD, DMSc (dr.med.) CURRICULUM VITAE May, 2020 1 Personal information Ulla Feldt-Rasmussen, MD, DMSc Professor, Chief Physician, Department of Medical Endocrinology PE 2132 Rigshospitalet, Blegdamsvej 9 2100 Copenhagen Denmark Born: 24 September 1950 Home address: Baunegårdsvej 21, 2820 Gentofte, Denmark Phone: +45 35452337/ +45 35451023 Home: +45 39615816 Fax: +45 35452240 Mobile: +45 24600158 E-mail: [email protected] Home: [email protected] Employment history • Department of Clinical Chemistry, Odense University Hospital Fellow (1974-1975); Resident (1975-1978); Researcher (1974-1978) • Faculty of Health Sciences, Odense University, Fellow (1978-1979) • Department of Medical Endocrinology, Herlev Hospital, Copenhagen University Resident (1979-1982); Consultant and Senior Lecturer (1987-1990); Senior Scientist (1987- 1990) • Consultant Advisor Europaeiske Travel Insurance and SOS International (1985-Present) • Hvidoere Hospital (diabetes hospital) Consultant and Senior Lecturer (1982-1983) • Department of Medical Endocrinology, Frederiksberg Hospital, Copenhagen University Consultant, Senior Lecturer and Senior Scientist (1983-1986) • Department of Internal Medicine, Gentofte Hospital, Copenhagen University Consultant and Senior Lecturer (1986-1987) • Rigshospitalet, Copenhagen University Hospital Head of Department and Senior Scientist (1990-present) • Faculty of Health Sciences, Copenhagen University Senior Lecturer (1980-1985); Associate Professor (1985-2010), Clinical Professor (2010- Present) • Consultant Advisor for Danish Agency for Patient Complaints (2016-Present) Qualifications • DMSc - Doctor of Medical Sciences (dr. med) 1983 Title of dissertation: "Serum Thyroglobulin and Thyroglobulin Autoantibodies in Thyroid Diseases. Pathogenic and Diagnostic Aspects" • Specialist in Endocrinology and Metabolism 1987 • Specialist in Internal Medicine 1987 • Qualified for professorship in Medical Endocrinology and Internal Medicine Copenhagen University 1992 2 • Qualified as Research Professor by Danish National Research Agency 2003 • Qualified for professorship in Medical Endocrinology and Internal Medicine Copenhagen University 2010 Administration • Head of the Research Laboratory at Lab of Medical Endocrinology, Rigshospitalet 1990- present • Head of Department of Medical Endocrinology PE, Rigshospitalet 1990 – 2010 • Management and leadership (H:S course) 2005 • Administrative Course on 'Service and Management' 1986 • Course in Administrative medicine SOSA (1982) Administrative and Academic Positions of Trust • Endocrine Society Clinical Guidelines Task Force (2018- ongoing) • Member of Academic Council subcommittee at Copenhagen University selecting Review Committees for DSc theses (2018-present) • Danish leading participant of EU European Group for Endocrine Rare disease ERN (2016- present) • American Thyroid Association Public Health Committee (2012- present) • Member of Scientific Board of Ydes Foundation (2014 – present) • Chairman of the Research Foundation of Danish Medical Association (2013 -2020) • International Leader of Research Group on internationalization of the thyroid related quality of life questionnaire ThyPRO (2013-present) • Member of Regional Ethics Committee (Region A) (2004 – present) • Member of Scientific Board of Eva Madura's Research Foundation (2008 - present) • Strategic Research Board, Danish Regions. Board Member (2008-2013) • MTV Strategic Council, Danish Health Board. Board Member (2007-2013) • National Danish Health Institute. Board Member (2007-2012) • Member of Scientific Board of Freddy and Kirsten Johansen's Research Foundation for medical research (2006-2020) • Danish Research Council. Member (2005-2013) • Danish Committees on Scientific Dishonesty. Board Member (2004-2015) • Fabry Registry, Advisory Board. Member (2002 - present) • Genetic Board, Rigshospitalet. Member (2000 - present) • Quality Board (Kvalitetsråd), Rigshospitalet. Member (2000-2003) • Board of Physicians, Rigshospitalet. Director (1997-2003) • Health Board for Clinical Biochemistry: Genetic Diagnostics in Clinical Biochemistry. Rigshospitalet. Member (1997-1998) • Research Council, Rigshospitalet. Board Member (1997-present) • Member of Clinical Public Affairs Board; Danish Endocrine Society (1997) • Honorary auditor for the accounts of European Thyroid Association (1997) • Member of National Academy of Clinical Biochemistry guidelines Board on thyroid Hormones and other thyroid related substances (1996) • Pfizer, KIMS Executive Advisory Board Member (1996-2005) • Board of Physicians, Rigshospitalet. Deputy Director (1995-1997) • Diabetes Council, Copenhagen (Diabetesudvalg/H:S) Member (1995-2000) • Copenhagen University Hospital, Rigshospitalet. Senate member (1995) • Pfizer, KIMS International Board. Member (1994 - present) • Community Bureau of Reference (BCR), European Union Member (1987 - 1995); Leader of project concerning preparation and stability of thyroglobulin reference material for use in 3 immunoassays. Resulted in CRM457 used globally for Tg assays and 2 very large detailed reports in ABC 1996. • Member of the Danish pituitary coordination group (1991-1996) • Member of working group, DSIM, recommendations for thyroid diagnosis and treatment (1993) • Medlem af arbejdsgruppe under dansk kirurgisk selskab vedrørende udarbejdelse af forslag om thyreoideakirurgiens strukturering og visitationsforhold i Danmark (1991) • Collaboration Committee, Dep Med, Gentofte University Hospital (1987- 1990) • Community Bureau of Reference, BCR, EU. Director (1986-1994) • Board of Safety and Department leader, Frederiksberg Universitet Hosp. (1983-1986) • Consultant at Autoimmune Laboratory, State Serum Institute on Autoimmune Thyroid Analyses. (1985-1990) • Board of Young Physicians (Reservelægerådsformand), Herlev University Hospital. Director (1981-1982) • Board of Acute Medical Admissions, Herlev University Hospital. Member (1979-1982) • Member of EORTC Thyroid Study Group on EU standardisation and collaboration on thyroid cancer (1980-1993) • Member of Project Group on planning of new Medicine Building, Frederiksberg Hospital (1984-1986) • Consultant and reagent provider for Serum Thyroglobulin assay at Finsen Institute (1984- 1990) • §9 Course on Safety (1984) • Clinical Biochemical collaboration between Departments, Odense University Hospital. Member (1977-1978) Teaching Apart from the activities mentioned below, I have during all the years been planning and teaching at numerous pre- and postgraduate courses both nationally and internationally. I have planned and conducted examinations for the medical students at KU 4 times per year. Over the years I have also been tutor for many visiting medical students and young doctors in specialist training from abroad, approx 2-6 per year • Adjungated Professor, Medical School, Messina University, Italy • Tutor for pregraduate medical student Anneke Stallman from Freiburg Germany (2005) • Copenhagen University. Member of Det Sundhedsvidenskabelige Fakultets eksamensankenævn (2001) • Lecturer at Folkeuniversitetet RUC: Autoimmunity in organs. (1998) • Lecturer at Folkeuniversitetet; “Autoimmuny in organs”. (1997) • Member of Theme for Endocrinology under 7.-10. semester teaching board (1997) • Member of 10. semesterudvalg in Medicine on behalf of Institute for Internal Medicine (1996) • Tutor, 2 weeks laboratory training for Ph.D. student Valérie Éstienne, Marseille, France (1997) • Laboratory of Endocrinology and Molecular Biology, Frederico II University, Naples, Italy (1996-1996) Visiting professor (1996-1996) • Organiser and teacher at Medical Faculty, Bucharest, Romania Senate member (1993) • Tutor, 2 weeks laboratory training for Ph.D. student Martha Channing, Amsterdam, Netherlands (1997) • Committee of Postgraduate medical Education (Lægelige uddannelsesudvalg), Herlev University Hospital (University / College). Member (1989-1990) 4 • Copenhagen University, Faculty of Health Sciences. Clinical Teacher in Internal Medicine (1987-1990) • Postgraduat tutor dept of medicine F, KAS Gentofte (1987) • Member of course organisation in Danish Thyroid Association (1986-1996) • Lecturer at Folkeuniversitet: Goitre and autoimmune diseases (1986) • Copenhagen University. Lecturer in Clinical Medicine (1984-1986) • Exam Scient, Odense University Lecturer in Clinical Medicine (1976-1976) • Odense University Hospital. Teacher at Exam Scient Education (1975-1976) Scientific Associations Membership • American Thyroid Association Membership from 1995 – present; Nomination Board member (2007- 2012); Public Health Board from 2012-present • Danish Society for Internal Medicine Membership from 1985 – present • Danish Endocrine Society Membership from 1985 – present; Board member from 1994- 2000 • Danish Thyroid Association Membership from 1985; Co-founder and Secretary-Treasurer (1985-1992); member of Educational Board (1990-1996) • Endocrine Society Membership from 1997 – present. Member of Subcommittee: Clinical Guidelines Task Force Group (2017- present) • EORTC Thyroid Study Group Membership from 1981 to 2002 (group dissolved); Secretary- Treasurer (1986-1992); Board member (1992-2002); President of subgroup committee (1984-1996); • European Neuroendocrine Association Membership from 1993 – present • European Society for Endocrinology Membership from 2005 – present; Nomination Board Member (2009-2014) • European Thyroid Association Membership from 1983 – present; Board member (1989- 1993)
Load more

Recommended publications
  • Te2, Part Iii
    TERMINOLOGIA EMBRYOLOGICA Second Edition International Embryological Terminology FIPAT The Federative International Programme for Anatomical Terminology A programme of the International Federation of Associations of Anatomists (IFAA) TE2, PART III Contents Caput V: Organogenesis Chapter 5: Organogenesis (continued) Systema respiratorium Respiratory system Systema urinarium Urinary system Systemata genitalia Genital systems Coeloma Coelom Glandulae endocrinae Endocrine glands Systema cardiovasculare Cardiovascular system Systema lymphoideum Lymphoid system Bibliographic Reference Citation: FIPAT. Terminologia Embryologica. 2nd ed. FIPAT.library.dal.ca. Federative International Programme for Anatomical Terminology, February 2017 Published pending approval by the General Assembly at the next Congress of IFAA (2019) Creative Commons License: The publication of Terminologia Embryologica is under a Creative Commons Attribution-NoDerivatives 4.0 International (CC BY-ND 4.0) license The individual terms in this terminology are within the public domain. Statements about terms being part of this international standard terminology should use the above bibliographic reference to cite this terminology. The unaltered PDF files of this terminology may be freely copied and distributed by users. IFAA member societies are authorized to publish translations of this terminology. Authors of other works that might be considered derivative should write to the Chair of FIPAT for permission to publish a derivative work. Caput V: ORGANOGENESIS Chapter 5: ORGANOGENESIS
    [Show full text]
  • Hypothalamus and Pituitary Gland Development in the Common Snapping Turtle, Chelydra Serpentina, and Disruption with Atrazine Exposure
    University of North Dakota UND Scholarly Commons Theses and Dissertations Theses, Dissertations, and Senior Projects January 2016 Hypothalamus And Pituitary Gland Development In The ommonC Snapping Turtle, Chelydra Serpentina, And Disruption With Atrazine Exposure Kathryn Lee Gruchalla Russart Follow this and additional works at: https://commons.und.edu/theses Recommended Citation Russart, Kathryn Lee Gruchalla, "Hypothalamus And Pituitary Gland Development In The ommonC Snapping Turtle, Chelydra Serpentina, And Disruption With Atrazine Exposure" (2016). Theses and Dissertations. 2069. https://commons.und.edu/theses/2069 This Dissertation is brought to you for free and open access by the Theses, Dissertations, and Senior Projects at UND Scholarly Commons. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of UND Scholarly Commons. For more information, please contact [email protected]. HYPOTHALAMUS AND PITUITARY GLAND DEVELOPMENT IN THE COMMON SNAPPING TURTLE, CHELYDRA SERPENTINA, AND DISRUPTION WITH ATRAZINE EXPOSURE by Kathryn Lee Gruchalla Russart Bachelor of Science, Minnesota State University, Mankato, 2006 A Dissertation Submitted to the Graduate Faculty of the University of North Dakota in partial fulfillment of the requirements for the degree of Doctor of Philosophy Grand Forks, North Dakota August 2016 Copyright 2016 Kathryn Russart ii iii PERMISSION Title Hypothalamus and Pituitary Gland Development in the Common Snapping Turtle, Chelydra serpentina, and Disruption with Atrazine Exposure Department Biology Degree Doctor of Philosophy In presenting this dissertation in partial fulfillment of the requirements for a graduate degree from the University of North Dakota, I agree that the library of this University shall make it freely available for inspection.
    [Show full text]
  • Nomina Histologica Veterinaria, First Edition
    NOMINA HISTOLOGICA VETERINARIA Submitted by the International Committee on Veterinary Histological Nomenclature (ICVHN) to the World Association of Veterinary Anatomists Published on the website of the World Association of Veterinary Anatomists www.wava-amav.org 2017 CONTENTS Introduction i Principles of term construction in N.H.V. iii Cytologia – Cytology 1 Textus epithelialis – Epithelial tissue 10 Textus connectivus – Connective tissue 13 Sanguis et Lympha – Blood and Lymph 17 Textus muscularis – Muscle tissue 19 Textus nervosus – Nerve tissue 20 Splanchnologia – Viscera 23 Systema digestorium – Digestive system 24 Systema respiratorium – Respiratory system 32 Systema urinarium – Urinary system 35 Organa genitalia masculina – Male genital system 38 Organa genitalia feminina – Female genital system 42 Systema endocrinum – Endocrine system 45 Systema cardiovasculare et lymphaticum [Angiologia] – Cardiovascular and lymphatic system 47 Systema nervosum – Nervous system 52 Receptores sensorii et Organa sensuum – Sensory receptors and Sense organs 58 Integumentum – Integument 64 INTRODUCTION The preparations leading to the publication of the present first edition of the Nomina Histologica Veterinaria has a long history spanning more than 50 years. Under the auspices of the World Association of Veterinary Anatomists (W.A.V.A.), the International Committee on Veterinary Anatomical Nomenclature (I.C.V.A.N.) appointed in Giessen, 1965, a Subcommittee on Histology and Embryology which started a working relation with the Subcommittee on Histology of the former International Anatomical Nomenclature Committee. In Mexico City, 1971, this Subcommittee presented a document entitled Nomina Histologica Veterinaria: A Working Draft as a basis for the continued work of the newly-appointed Subcommittee on Histological Nomenclature. This resulted in the editing of the Nomina Histologica Veterinaria: A Working Draft II (Toulouse, 1974), followed by preparations for publication of a Nomina Histologica Veterinaria.
    [Show full text]
  • BGD B Lecture Notes Docx
    BGD B Lecture notes Lecture 1: GIT Development Mark Hill Trilaminar contributions • Overview: o A simple tube is converted into a complex muscular, glandular and duct network that is associated with many organs • Contributions: o Endoderm – epithelium of the tract, glands, organs such as the liver/pancreas/lungs o Mesoderm (splanchnic) – muscular wall, connective tissue o Ectoderm (neural crest – muscular wall neural plexus Gastrulation • Process of cell migration from the epiblast through the primitive streak o Primitive streak forms on the bilaminar disk o Primitive streak contains the primitive groove, the primitive pit and the primitive node o Primitive streak defines the body axis, the rostral caudal ends, and left and right sides Thus forms the trilaminar embryo – ectoderm, mesoderm, endoderm • Germ cell layers: o ectoderm – forms the nervous system and the epidermis epithelia 2 main parts • midline neural plate – columnar epithelium • lateral surface ectoderm – cuboidal, containing sensory placodes and skin/hair/glands/enamel/anterior pituitary epidermis o mesoderm – forms the muscle, skeleton, and connective tissue cells migrate second migrate laterally, caudally, rostrally until week 4 o endoderm – forms the gastrointestinal tract epithelia, the respiratory tract and the endocrine system cells migrate first and overtake the hypoblast layer line the primary yolk sac to form the secondary yolk sac • Membranes: o Rostrocaudal axis Ectoderm and endoderm form ends of the gut tube, no mesoderm At each end, form the buccopharyngeal
    [Show full text]
  • |||GET||| Pancreatic Islet Biology 1St Edition
    PANCREATIC ISLET BIOLOGY 1ST EDITION DOWNLOAD FREE Anandwardhan A Hardikar | 9783319453057 | | | | | The Evolution of Pancreatic Islets Advanced search. The field of regenerative medicine is rapidly evolving and offers great hope for the nearest future. Easily read eBooks on Pancreatic Islet Biology 1st edition phones, computers, or any eBook readers, including Kindle. Help Learn to edit Community portal Recent changes Upload file. Pancreatic Islet Biologypart of the Stem Cell Biology and Regenerative Medicine series, is essential reading for researchers and clinicians in stem cells or endocrinology, especially those focusing on diabetes. Because the beta cells in the pancreatic islets Pancreatic Islet Biology 1st edition selectively destroyed by an autoimmune process in type 1 diabetesclinicians and researchers are actively pursuing islet transplantation as a means of restoring physiological beta cell function, which would offer an alternative to a complete pancreas transplant or artificial pancreas. Strategies to improve islet yield from chronic pancreatitis pancreases intended for islet auto-transplantation 6. About this book This comprehensive volume discusses in vitro laboratory development of insulin-producing cells. Junghyo Jo, Deborah A. Show all. Comparative Analysis of Islet Development. Leibson A. However, type 1 diabetes is the result of the autoimmune destruction of beta cells in the pancreas. Islets can influence each other through paracrine and autocrine communication, and beta cells are coupled electrically to six to seven other beta cells but not to other cell types. Pancreatic Islet Biologypart of the Stem Cell Biology and Regenerative Medicine Pancreatic Islet Biology 1st edition, is essential reading for researchers and clinicians in stem cells or endocrinology, especially those focusing on diabetes.
    [Show full text]
  • 26 April 2010 TE Prepublication Page 1 Nomina Generalia General Terms
    26 April 2010 TE PrePublication Page 1 Nomina generalia General terms E1.0.0.0.0.0.1 Modus reproductionis Reproductive mode E1.0.0.0.0.0.2 Reproductio sexualis Sexual reproduction E1.0.0.0.0.0.3 Viviparitas Viviparity E1.0.0.0.0.0.4 Heterogamia Heterogamy E1.0.0.0.0.0.5 Endogamia Endogamy E1.0.0.0.0.0.6 Sequentia reproductionis Reproductive sequence E1.0.0.0.0.0.7 Ovulatio Ovulation E1.0.0.0.0.0.8 Erectio Erection E1.0.0.0.0.0.9 Coitus Coitus; Sexual intercourse E1.0.0.0.0.0.10 Ejaculatio1 Ejaculation E1.0.0.0.0.0.11 Emissio Emission E1.0.0.0.0.0.12 Ejaculatio vera Ejaculation proper E1.0.0.0.0.0.13 Semen Semen; Ejaculate E1.0.0.0.0.0.14 Inseminatio Insemination E1.0.0.0.0.0.15 Fertilisatio Fertilization E1.0.0.0.0.0.16 Fecundatio Fecundation; Impregnation E1.0.0.0.0.0.17 Superfecundatio Superfecundation E1.0.0.0.0.0.18 Superimpregnatio Superimpregnation E1.0.0.0.0.0.19 Superfetatio Superfetation E1.0.0.0.0.0.20 Ontogenesis Ontogeny E1.0.0.0.0.0.21 Ontogenesis praenatalis Prenatal ontogeny E1.0.0.0.0.0.22 Tempus praenatale; Tempus gestationis Prenatal period; Gestation period E1.0.0.0.0.0.23 Vita praenatalis Prenatal life E1.0.0.0.0.0.24 Vita intrauterina Intra-uterine life E1.0.0.0.0.0.25 Embryogenesis2 Embryogenesis; Embryogeny E1.0.0.0.0.0.26 Fetogenesis3 Fetogenesis E1.0.0.0.0.0.27 Tempus natale Birth period E1.0.0.0.0.0.28 Ontogenesis postnatalis Postnatal ontogeny E1.0.0.0.0.0.29 Vita postnatalis Postnatal life E1.0.1.0.0.0.1 Mensurae embryonicae et fetales4 Embryonic and fetal measurements E1.0.1.0.0.0.2 Aetas a fecundatione5 Fertilization
    [Show full text]
  • Why Should Growth Hormone (GH) Be Considered a Promising Therapeutic Agent for Arteriogenesis? Insights from the GHAS Trial
    cells Review Why Should Growth Hormone (GH) Be Considered a Promising Therapeutic Agent for Arteriogenesis? Insights from the GHAS Trial Diego Caicedo 1,* , Pablo Devesa 2, Clara V. Alvarez 3 and Jesús Devesa 4,* 1 Department of Angiology and Vascular Surgery, Complejo Hospitalario Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain 2 Research and Development, The Medical Center Foltra, 15886 Teo, Spain; [email protected] 3 . Neoplasia and Endocrine Differentiation Research Group. Center for Research in Molecular Medicine and Chronic Diseases (CIMUS). University of Santiago de Compostela, 15782. Santiago de Compostela, Spain; [email protected] 4 Scientific Direction, The Medical Center Foltra, 15886 Teo, Spain * Correspondence: [email protected] (D.C.); [email protected] (J.D.); Tel.: +34-981-800-000 (D.C.); +34-981-802-928 (J.D.) Received: 29 November 2019; Accepted: 25 March 2020; Published: 27 March 2020 Abstract: Despite the important role that the growth hormone (GH)/IGF-I axis plays in vascular homeostasis, these kind of growth factors barely appear in articles addressing the neovascularization process. Currently, the vascular endothelium is considered as an authentic gland of internal secretion due to the wide variety of released factors and functions with local effects, including the paracrine/autocrine production of GH or IGF-I, for which the endothelium has specific receptors. In this comprehensive review, the evidence involving these proangiogenic hormones in arteriogenesis dealing with the arterial occlusion and making of them a potential therapy is described. All the elements that trigger the local and systemic production of GH/IGF-I, as well as their possible roles both in physiological and pathological conditions are analyzed.
    [Show full text]
  • Nomina Histologica Veterinaria
    NOMINA HISTOLOGICA VETERINARIA Submitted by the International Committee on Veterinary Histological Nomenclature (ICVHN) to the World Association of Veterinary Anatomists Published on the website of the World Association of Veterinary Anatomists www.wava-amav.org 2017 CONTENTS Introduction i Principles of term construction in N.H.V. iii Cytologia – Cytology 1 Textus epithelialis – Epithelial tissue 10 Textus connectivus – Connective tissue 13 Sanguis et Lympha – Blood and Lymph 17 Textus muscularis – Muscle tissue 19 Textus nervosus – Nerve tissue 20 Splanchnologia – Viscera 23 Systema digestorium – Digestive system 24 Systema respiratorium – Respiratory system 32 Systema urinarium – Urinary system 35 Organa genitalia masculina – Male genital system 38 Organa genitalia feminina – Female genital system 42 Systema endocrinum – Endocrine system 45 Systema cardiovasculare et lymphaticum [Angiologia] – Cardiovascular and lymphatic system 47 Systema nervosum – Nervous system 52 Receptores sensorii et Organa sensuum – Sensory receptors and Sense organs 58 Integumentum – Integument 64 INTRODUCTION The preparations leading to the publication of the present first edition of the Nomina Histologica Veterinaria has a long history spanning more than 50 years. Under the auspices of the World Association of Veterinary Anatomists (W.A.V.A.), the International Committee on Veterinary Anatomical Nomenclature (I.C.V.A.N.) appointed in Giessen, 1965, a Subcommittee on Histology and Embryology which started a working relation with the Subcommittee on Histology of the former International Anatomical Nomenclature Committee. In Mexico City, 1971, this Subcommittee presented a document entitled Nomina Histologica Veterinaria: A Working Draft as a basis for the continued work of the newly-appointed Subcommittee on Histological Nomenclature. This resulted in the editing of the Nomina Histologica Veterinaria: A Working Draft II (Toulouse, 1974), followed by preparations for publication of a Nomina Histologica Veterinaria.
    [Show full text]
  • The Feed of Local Beef Bone Marrow Substitution During Pregnancy Affects the Increase in Growth Hormone Offsprings Production of Thirty and Sixty Days Old Mice
    J Food Sci Nutr Res 2019; 2 (4): 316-326 DOI: 10.26502/jfsnr.2642-11000030 Research Article The Feed of Local Beef Bone Marrow Substitution during Pregnancy affects the Increase in Growth Hormone Offsprings Production of Thirty and Sixty Days Old Mice I Made Tangkas1,4*, Ahmad Sulaeman1, Faisal Anwar1, Agik Suprayogi2, Sri Estuningsih3 1Department of Community Nutrition, Faculty of Human Ecology, Bogor Agriculture University, Bogor, Indonesia 2Department of Anatomy, Physiology and Pharmacology, Faculty of Veterinary Medicine Bogor Agriculture University, Bogor, Indonesia 3Pathology Reproductive Clinic Department, Faculty of Veterinary Medicine Bogor Agriculture University, Bogor, Indonesia 4Department of Chemistry Education, Faculty of Teacher Training and Education Tadulako University of Palu, Palu, Indonesia *Corresponding Author: I Made Tangkas, Department of Community Nutrition, Faculty of Human Ecology, Bogor Agriculture University, Bogor 16680, Indonesia, E-mail: [email protected] Received: 04 October 2019; Accepted: 17 October 2019; Published: 21 October 2019 Citation: I Made Tangkas, Ahmad Sulaeman, Faisal Anwar, Agik Suprayogi, Sri Estuningsih. The Feed of Local Beef Bone Marrow Substitution during Pregnancy affects the Increase in Growth Hormone Offsprings Production of Thirty and Sixty Days Old Mice. Journal of Food Science and Nutrition Research 2 (2019): 316-326. Abstract Growth hormone (GH) deficiency during the growth pituitary cell proliferation seen from the potential of the phase will cause the disruption, especially in phases of mice gland that produces the GH. The design of the infant, childhood, and puberty. Local beef bone marrow research uses a complete randomized design (RAL) in Central Sulawesi of Indonesia contains fatty and with a single factor. Fifty female rats and twenty male amino acids, which needed for supporting the rats were adapted for two weeks after the estrus was proliferation of somatotroph cells of fetal pituitary.
    [Show full text]
  • The Effects of Growth Hormone on Opioid-Induced Toxicity in Vitro
    Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 279 The effects of growth hormone on opioid-induced toxicity in vitro ERIK NYLANDER ACTA UNIVERSITATIS UPSALIENSIS ISSN 1651-6192 ISBN 978-91-513-0765-7 UPPSALA urn:nbn:se:uu:diva-393940 2019 Dissertation presented at Uppsala University to be publicly examined in B21, Biomedicinskt centrum (BMC), Husargatan 3, Uppsala, Friday, 22 November 2019 at 09:15 for the degree of Doctor of Philosophy (Faculty of Pharmacy). The examination will be conducted in English. Faculty examiner: Associate Professor Alexis Bailey (St. George’s University of London). Abstract Nylander, E. 2019. The effects of growth hormone on opioid-induced toxicity in vitro. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 279. 60 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-513-0765-7. There is an ongoing opioid crisis in the United States that is portrayed by a large number of opioid-related deaths. Many of these cases involve commonly used prescription opioids, such as morphine, oxycodone, fentanyl, and methadone. This is concerning and highlights the problems associated with long-term opioid treatment. In addition to opioid-related deaths, long-term opioid use may impact higher brain functions, such as cognitive function. The cause of cognitive decline following opioid treatment may be associated with increased neuronal cell death, inhibited neurogenesis, and altered volumes of specific brain regions important for cognition. Growth hormone (GH), a pituitary hormone regulated by the hypothalamic somatotropic axis, may counteract several of these effects. The hormone, alongside with its mediator insulin- like growth factor-1 (IGF-1), is associated with pro-cognitive effects and display promising neuroprotective actions in the CNS.
    [Show full text]
  • Wmuws, D0CT0R 0F PHIL0S0PHY
    PRECURSOR AND GENE STRUCTURE OP A GROWTH HORMONE-RELEASING HORMONE-LIKE MOLECULE AND PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE FROM SOCKEYE SALMON BRAIN David B . Parker B.Sc., Simon Fraser University, 1978 M.Sc., Simon Fraser University, 1985 h Dissertation submitted in Partial Fulfillment of the Requirements for the Degree of ACCRI'TEO W i i l t y wmuws, D0CT0R 0F PHIL0S0PHY at*.- We accept this thesis as conforming . y AN to the required standard J A** A m f \ * ' ” *" ite 'fe stLAp JC& l Dr, N.M. Sherwood/ Supervisor (Dept, of Biology) Dr, G .0. Macjcie, Departmj^fTtal Member (Dept, of Biology) — — ----- v — — -- Dr. R.D. Burkji,.departmental Member (Dept, of Biology) D r , T.W.^ Peairson, Outside Member (Dept, of Biochemistry) ~ r - t - ----------------- -— 1— ----------- ------------- --------------- ---------------- - ———-------- - Dr. C.Jj. Hew, CExternal Examiner) ©DAVID B. PARKER, 1992 University of Victoria All rights reserved. This dissertation may not be reproduced in whole or part, by photocopying or other means, without permission of the author II Supervisor? Dr. Nancy M. Sherwood ABSTRACT Growth Hormone-releasing hormone (GHRH) is a neuropeptide which stimulates the synthesis and release of growth hormone (GH) from the pituitary gland. The primary structure of this peptide has been identified in 7 mammalian species while the gene has been isolated from only rat and human. GHRH is a member of the glucagon superfamily which includes vasoactive intestinal peptide (VXP), glucagon, secretin, peptide histidine methionine (PHM), gastric inhibitory peptide (GXP) and a recently identified peptide, pituitary adenylate cyclase activating polypeptide (PACAP). The evolutionary relationships of this superfamily are not well understood because the gene structure of these molecules has only been identified in mammals.
    [Show full text]
  • Brain IGF-1 Receptors Control Mammalian Growth and Lifespan Through a Neuroendocrine Mechanism
    Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism. Laurent Kappeler, Carlos de Magalhaes Filho, Joëlle Dupont, Patricia Leneuve, Pascale Cervera, Laurence Périn, Catherine Loudes, Annick Blaise, Rüdiger Klein, Jacques Epelbaum, et al. To cite this version: Laurent Kappeler, Carlos de Magalhaes Filho, Joëlle Dupont, Patricia Leneuve, Pascale Cervera, et al.. Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mecha- nism.. PLoS Biology, Public Library of Science, 2008, 6 (10), pp.e254. 10.1371/journal.pbio.0060254. inserm-00707822 HAL Id: inserm-00707822 https://www.hal.inserm.fr/inserm-00707822 Submitted on 13 Jun 2012 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. PLoS BIOLOGY Brain IGF-1 Receptors Control Mammalian Growth and Lifespan through a Neuroendocrine Mechanism [ [ Laurent Kappeler1 , Carlos De Magalhaes Filho1,2 , Joe¨lle Dupont3, Patricia Leneuve1, Pascale Cervera4, Laurence Pe´rin1, Catherine Loudes5, Annick Blaise1,2,Ru¨ diger Klein6, Jacques Epelbaum5, Yves Le Bouc1,2, Martin Holzenberger1* 1 INSERM U893, Hoˆpital Saint-Antoine, Paris, France, 2 Universite´ Pierre-et-Marie-Curie, Paris, France, 3 INRA, Nouzilly, France, 4 Service d’Anatomopathologie, Hoˆpital Saint- Antoine, Paris, France, 5 INSERM U549, Centre Paul Broca, Paris, France, 6 Department of Molecular Neurobiology, Max-Planck Institute of Neurobiology, Munich-Martinsried, Germany Mutations that decrease insulin-like growth factor (IGF) and growth hormone signaling limit body size and prolong lifespan in mice.
    [Show full text]